BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23975096)

  • 1. Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.
    Fisher JL; Housley PR
    Cell Mol Neurobiol; 2013 Nov; 33(8):1099-108. PubMed ID: 23975096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of different kainate receptor subunits to the properties of recombinant homomeric and heteromeric receptors.
    Fisher MT; Fisher JL
    Neuroscience; 2014 Oct; 278():70-80. PubMed ID: 25139762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly and Trafficking of Homomeric and Heteromeric Kainate Receptors with Impaired Ligand Binding Sites.
    Scholefield CL; Atlason PT; Jane DE; Molnár E
    Neurochem Res; 2019 Mar; 44(3):585-599. PubMed ID: 30302614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit.
    Fisher JL
    Neuropharmacology; 2014 Oct; 85():9-17. PubMed ID: 24859608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of homomeric and heteromeric kainate receptors by the auxiliary subunit Neto1.
    Fisher JL; Mott DD
    J Physiol; 2013 Oct; 591(19):4711-24. PubMed ID: 23798491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct functional roles of subunits within the heteromeric kainate receptor.
    Fisher JL; Mott DD
    J Neurosci; 2011 Nov; 31(47):17113-22. PubMed ID: 22114280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of kainate receptor subunit ratios in mouse brain using novel chimeric protein standards.
    Watanabe-Iida I; Konno K; Akashi K; Abe M; Natsume R; Watanabe M; Sakimura K
    J Neurochem; 2016 Jan; 136(2):295-305. PubMed ID: 26448475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subunit-specific desensitization of heteromeric kainate receptors.
    Mott DD; Rojas A; Fisher JL; Dingledine RJ; Benveniste M
    J Physiol; 2010 Feb; 588(Pt 4):683-700. PubMed ID: 20026616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly stoichiometry of the GluK2/GluK5 kainate receptor complex.
    Reiner A; Arant RJ; Isacoff EY
    Cell Rep; 2012 Mar; 1(3):234-40. PubMed ID: 22509486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
    Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
    Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Architecture and structural dynamics of the heteromeric GluK2/K5 kainate receptor.
    Khanra N; Brown PM; Perozzo AM; Bowie D; Meyerson JR
    Elife; 2021 Mar; 10():. PubMed ID: 33724189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structural arrangement and dynamics of the heteromeric GluK2/GluK5 kainate receptor as determined by smFRET.
    Litwin DB; Paudyal N; Carrillo E; Berka V; Jayaraman V
    Biochim Biophys Acta Biomembr; 2020 Jan; 1862(1):183001. PubMed ID: 31194959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Validation of Heteromeric Kainate Receptor Models.
    Paramo T; Brown PMGE; Musgaard M; Bowie D; Biggin PC
    Biophys J; 2017 Nov; 113(10):2173-2177. PubMed ID: 28935133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand binding is a critical requirement for plasma membrane expression of heteromeric kainate receptors.
    Valluru L; Xu J; Zhu Y; Yan S; Contractor A; Swanson GT
    J Biol Chem; 2005 Feb; 280(7):6085-93. PubMed ID: 15583001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly and intracellular distribution of kainate receptors is determined by RNA editing and subunit composition.
    Ball SM; Atlason PT; Shittu-Balogun OO; Molnár E
    J Neurochem; 2010 Sep; 114(6):1805-18. PubMed ID: 20626562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc Modulates Olfactory Bulb Kainate Receptors.
    Blakemore LJ; Trombley PQ
    Neuroscience; 2020 Jan; 428():252-268. PubMed ID: 31874243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of kainate receptor GluK2 and GluK5 knockout mice in a pure genetic background.
    Iida I; Konno K; Natsume R; Abe M; Watanabe M; Sakimura K; Terunuma M
    Behav Brain Res; 2021 May; 405():113194. PubMed ID: 33631192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial agonism in heteromeric GLUK2/GLUK5 kainate receptor.
    Paudyal N; Das A; Carrillo E; Berka V; Jayaraman V
    Proteins; 2023 Aug; ():. PubMed ID: 37526035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subunit-selective iGluR antagonists can potentiate heteromeric receptor responses by blocking desensitization.
    Pollok S; Reiner A
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25851-25858. PubMed ID: 32999066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.
    Fisher JL
    Neuropharmacology; 2015 Dec; 99():471-80. PubMed ID: 26277340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.